Beyond density: mapping the functional landscapes of macrophage-T lymphocyte niches in the tumor microenvironment - Takeaways - MDSpire

Beyond density: mapping the functional landscapes of macrophage-T lymphocyte niches in the tumor microenvironment

  • By

  • Serena Zilio

  • Adrien Rouault Montecino

  • Malvina Seradj

  • Ilaria Marigo

  • Armelle Prévost-Blondel

  • Elisa Peranzoni

  • Nadège Bercovici

  • July 2, 2026

  • 0 min

Share

  • 1

    The spatial arrangement of tumor-associated macrophages and T cells is a key regulator of clinical outcomes in solid tumors.

  • 2

    Tumor-infiltrating lymphocytes and tumor-associated macrophages exhibit significant heterogeneity that influences tumor progression and therapy response.

  • 3

    High-resolution spatial technologies have enhanced the mapping of TAM and TIL interactions, revealing distinct microanatomical niches.

  • 4

    The organization of TAM-TIL interactions within tumor niches impacts anti-tumor immunity and can predict immunotherapy response.

  • 5

    Integrating multi-omics and AI-driven algorithms is essential for transitioning to niche-centric drug development in immuno-oncology.

Original Source(s)

Beyond density: mapping the functional landscapes of macrophage-T lymphocyte niches in the tumor microenvironment

  • by Serena Zilio, Adrien Rouault Montecino, Malvina Seradj, Ilaria Marigo, Armelle Prévost-Blondel, Elisa Peranzoni, Nadège Bercovici

  • July 2, 2026

Related Content

EGP-Net: a lung nodule segmentation network integrating edge guidance and pyramidal multi-scale contextual attention mechanisms

Multimodal imaging features of primary breast epithelial–myoepithelial carcinoma: a case report and literature review

ASCO26: Sara Tolaney, MD, MPH, ASCENT-04

Dana-Farber Cancer Institute's Dr. Sara Tolaney presented a subgroup analysis of the ASCENT-04 study based on biomarkers. Across all subgroups, patients who received sacituzumab govitecan plus pembro as first-line therapy had longer progression-free survival compared to standard therapy.

  • July 1, 2026

  • 1 min